Clinical trials show that Liquid BioCell™ improves joint mobility, helps promote healthy cartilage and connective tissue, and promotes joint lubrication. Unlike other ingredients, Liquid BioCell™ offers a patented matrix of hydrolyzed collagen type II, hyaluronic acid (HA) and chondroitin sulfate, and its patented manufacturing process produces an ideal molecular weight that the body can effectively absorb. Liquid BioCell™ mirrors the joint's natural composition, which is another reason why the body readily accepts it.

A human bioavailability study demonstrated that within 28 days, daily intake of Liquid BioCell™ led to a 60- fold increase of hyaluronic acid in the body.

Hyaluronic acid (HA) not only helps keep the cartilage that cushions joints strong and flexible, but also helps increase supplies of joint-lubricating synovial fluid.

In an 8-week human clinical trial, 90% of subjects with chronic joint discomfort experienced a 40% improvement in physical activity and with continued use, many experienced significant mobility.

A 10- week trial enrolling subjects at an advanced stage of joint discomfort showed that more than 70% experienced a significant reduction of stiffness and soreness, improving their daily activities.

Additional recent studies concluded that hydrolyzed collagen type II, which is a primary component of Liquid BioCell™, can directly stimulate collagen production, and promote healthy cartilage and connective tissue.